|
gptkbp:instance_of
|
gptkb:physicist
|
|
gptkbp:bfsLayer
|
7
|
|
gptkbp:bfsParent
|
gptkb:OHSU_Center_for_Neuromuscular_Research
|
|
gptkbp:advocates_for
|
gptkb:Muscular_Dystrophy_Association
gptkb:Cure_Duchenne
gptkb:Duchenne_Parent_Project
Parent Project Muscular Dystrophy
|
|
gptkbp:affects
|
muscle strength
muscles
|
|
gptkbp:associated_with
|
gptkb:hospital
respiratory issues
scoliosis
joint contractures
|
|
gptkbp:caused_by
|
genetic mutations
|
|
gptkbp:clinical_trial
|
drug development
ongoing research
biomarker studies
experimental treatments
gene editing studies
|
|
gptkbp:descendant
|
autosomal dominant
autosomal recessive
X-linked recessive
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Muscular Dystrophy
|
|
gptkbp:impact
|
gptkb:independence
mobility
quality of life
social challenges
financial burden
emotional challenges
mobility issues
independence loss
|
|
gptkbp:is_involved_in
|
gptkb:local_chapters
family support
online communities
peer support
|
|
gptkbp:is_popular_in
|
1 in 20,000 females
1 in 3,500 males
|
|
gptkbp:lifespan
|
varies by type
shortened in severe cases
|
|
gptkbp:notable_event
|
gptkb:Stephen_Hawking
gptkb:Jesse_C._Smith
gptkb:Jesse_Billauer
gptkb:Darius_Weems
Duchenne Muscular Dystrophy patients
|
|
gptkbp:premiered_on
|
childhood
early adulthood
adolescence
|
|
gptkbp:public_awareness
|
gptkb:charity
September
increased through campaigns
awareness months
|
|
gptkbp:research
|
gptkb:physicist
stem cell therapy
|
|
gptkbp:research_focus
|
gptkb:physicist
stem cell therapy
exon skipping
|
|
gptkbp:social_responsibility
|
genetic testing
muscle biopsy
|
|
gptkbp:symptoms
|
muscle weakness
muscle wasting
|
|
gptkbp:treatment
|
gptkb:hospital
medications
physical therapy
occupational therapy
|
|
gptkbp:type_of
|
gptkb:Duchenne_Muscular_Dystrophy
gptkb:Becker_Muscular_Dystrophy
gptkb:Facioscapulohumeral_Muscular_Dystrophy
gptkb:Limb-girdle_Muscular_Dystrophy
gptkb:Myotonic_Dystrophy
|